- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Hodgkin's relapse for 'Survivor' winner Zohn
After twenty months of remission, television reality show winner Ethan Zohn has learned that his Hodgkin's lymphoma has relapsed.
The disease has apparently been found to have localized in his chest. Despite this setback, Zohn, who has become a motivational speaker and philanthropist, will still run in the upcoming New York City Marathon.
Zohn has indicated that for treatment this time, his doctors may give him Adcetris (formerly known as SGN-35), the Seattle Genetics HL treatment approved this past August by the FDA for specific indications within both Hodgkin's and Anaplastic Large Cell Lymphoma.
Zohn and his doctors have also discussed the possibility of a bone marrow transplant.
Source: Los Angeles Times